Company Filing History:
Years Active: 2016-2019
Title: Christine Landlinger: Innovator in Vaccine Development
Introduction
Christine Landlinger is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of vaccine development, particularly in the area of inhibiting C5a. With a total of two patents to her name, Landlinger is recognized for her innovative approaches to immunology.
Latest Patents
Her latest patents include a method of inhibiting C5a, which relates to a vaccine comprising at least one peptide consisting of 7 to 19 amino acid residues. This peptide is designed to enhance immune response by coupling or fusing it to a carrier that includes T-cell epitopes. Another notable patent involves methods for inhibiting C5a with C5a peptides that are also coupled or fused to a carrier protein, ensuring effective immunogenicity.
Career Highlights
Christine Landlinger is currently associated with Affiris AG, a company known for its innovative vaccine technologies. Her work has been pivotal in advancing the understanding and treatment of various diseases through targeted immunotherapy.
Collaborations
Some of her notable coworkers include Guenther Staffler and Frank Mattner, who have collaborated with her on various projects aimed at enhancing vaccine efficacy.
Conclusion
Christine Landlinger stands out as a key figure in the field of vaccine innovation, with her patents reflecting her commitment to advancing medical science. Her contributions continue to influence the development of effective immunotherapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.